ARUP CONSULT
LIVE

Serial Number

78865966

Owner

Associated Regional and University Pathologists, Inc.

Attorney

Lester K. Essig

First Use Date

Sep 29, 2006

Filing Date

Apr 20, 2006

Add to watchlist:

No watchlists yet
View on USPTO

ARUP CONSULT Trademark

Serial Number: 78865966 • Registration: 3494029

ARUP CONSULT is a trademark filed by Associated Regional and University Pathologists, Inc. on April 20, 2006. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Associated Regional and University Pathologists, Inc.

500 Chipeta Way
Salt Lake City, UT 84108

Entity Type: 03

ARUP LABORATORIES, INC. (27 trademarks)

500 CHIPETA WAY
SALT LAKE CITY, UT 84108

Entity Type: 03

Trademark Details

Filing Date

April 20, 2006

Registration Date

August 26, 2008

First Use Anywhere

September 29, 2006

First Use in Commerce

September 29, 2006

Published for Opposition

September 4, 2007

Goods & Services

Providing medical information online to pathologists, physicians and other healthcare practitioners over a global communications network, through handheld electronic devices and other means, with respect to tests, test results, test analysis, test trends, test effectiveness, test advisability, test selection, test ordering, test ordering management, test ordering procedures, test ordering efficiency, test ordering effectiveness, utilization management services, medical condition, health condition, and diagnosis in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microwave processing, microscopy, electron microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, health care, and child health care; and evaluating data, identifying trends, designing reports, reporting, delivering reports and making recommendations with respect to test results, test analysis, test trends, test efficiency, test effectiveness, test advisability, test selection, test ordering, test ordering management, test ordering procedures, test ordering efficiency, test ordering effectiveness, utilization management services, medical condition, health condition, and diagnosis in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microwave processing, microscopy, electron microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, health care, and child health care

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 28, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2026 REAP
COUNTERCLAIM OPP. NO. 999999
May 7, 2024 CCON
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 1, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 1, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 1, 2018 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 1, 2018 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 24, 2018 E89R
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Sep 11, 2014 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 11, 2014 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Aug 27, 2014 815F
PAPER RECEIVED
Aug 27, 2014 MAIL
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 20, 2013 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2008 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jul 22, 2008 REGV
ASSIGNED TO LIE
Jul 21, 2008 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 21, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 14, 2008 SUPC
PAPER RECEIVED
May 29, 2008 MAIL
USE AMENDMENT FILED
May 27, 2008 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 27, 2007 NOAM
PUBLISHED FOR OPPOSITION
Sep 4, 2007 PUBO
NOTICE OF PUBLICATION
Aug 15, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 27, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2007 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 5, 2007 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 2, 2007 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 7, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2007 CNSA
AMENDMENT FROM APPLICANT ENTERED
Apr 27, 2007 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2007 CRFA
ASSIGNED TO LIE
Apr 27, 2007 ALIE
PAPER RECEIVED
Mar 28, 2007 MAIL
NON-FINAL ACTION MAILED
Sep 26, 2006 CNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2006 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2006 DOCK
NEW APPLICATION ENTERED
Apr 26, 2006 NWAP